[Infant exposure to potentially toxic plasticizers in products for oral use]

Lilia Patricia Bustamante-Montes1, Beatriz Lizama-Soberanis, Flavio Vázquez-Moreno

  • 1Universidad Autónoma del Estado de Mexico, Toluca, Estado de México, México.

Salud Publica De Mexico
|December 31, 2004
PubMed

Insights

Oral product use in young children was 13%, with phthalate exposure below recommended limits. However, other sources may increase total exposure, necessitating further research into potential health effects.

Area of Science:

  • Environmental Health
  • Pediatric Toxicology
  • Consumer Product Safety

Background:

  • Oral products are commonly used by children under three.
  • Phthalates are plasticizers found in many consumer products and are potential endocrine disruptors.
  • Assessing infant exposure to phthalates is crucial for public health.

Purpose of the Study:

  • To determine the prevalence of oral product use in children under three years of age.
  • To quantify phthalate concentrations in these products.
  • To estimate the daily phthalate intake in young children.

Main Methods:

  • Household interviews with 199 mothers in Toluca, Mexico.
  • Analysis of oral product samples using gas chromatography.
  • Calculation of daily phthalate intake based on product concentrations and usage.

Main Results:

  • Oral product use prevalence was 13% among children under three.
  • Higher usage was observed in male infants from lower socioeconomic backgrounds.
  • Mean daily phthalate exposure was 13.94 microg/kg/day, with concentrations up to 67% by weight.

Conclusions:

  • Phthalate intake from oral products did not exceed international limits.
  • Potential for increased total phthalate dose from other sources exists.
  • Further investigation into additional exposure routes and biomarker assessment is recommended due to phthalates' reproductive toxicity concerns.
Abstract

Related Concept Videos

Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...